Therapeutics Therapeutics Home Tools Email Share How would you like to share? Facebook Twitter LinkedIn Back to the Top Find a Therapeutic By Name LMTM Neflamapomid AAB-003 AADvac-1 ABT 418 ABT-089 ABT-288 ABT-384 ABT-957 ABvac 40 AC-1204 Acetyl-l-carnitine HCI ACI-24 ACI-35 Acitretin Aducanumab AF 102B Affitope AD02 AGB101 Allopregnanolone Alpha-Tocopherol Alzhemed™ ALZT-OP1 AN-1792 Anavex 2-73 Aripiprazole Atomoxetine Atorvastatin Avagacestat AVP-786 AVP-923 AZD1446 AZD3293 AZD3480 Azeliragon BAN2401 Bapineuzumab Besipirdine HCl Bexarotene BI 1181181 BI 409306 BMS-986168 Brexpiprazole C2N 8E12 CAD106 Carvedilol Celecoxib CERE-110 Cerebrolysin CHF 5074 Circadin Clioquinol CNP520 COGNIShunt™ Continuous Positive Airway Pressure Crenezumab CT1812 Curcumin CX516 Dapsone Davunetide Deep Brain Stimulation-fornix Dexpramipexole Dimebon Docosahexaenoic acid (DHA) Donepezil EHT 0202 Elenbecestat ELND005 Encenicline Epigallocatechin Gallate (EGCG) Epothilone D Eptastigmine Estrogen Etanercept EVP-0962 Exendin-4 Flurizan™ FRM-0334 G-CSF Galantamine Gammagard® Gamunex Gantenerumab GC 021109 Gemfibrozil GLN-1062 GSK239512 GSK2647544 GSK933776 HF0220 Huperzine A Ibuprofen Idalopirdine Idebenone Intepirdine ITI-007 JNJ-54861911 Ketasyn Ladostigil Leuprolide Linopirdine Liraglutide Lornoxicam Lu AF20513 LU25-109 LY2599666 LY2886721 LY3002813 LY3202626 LY3303560 Masitinib MEDI1814 Melatonin MEM 1003 Memantine Metrifonate Milameline Minocycline MK-7622 MKC-231 MSDC-0160 Naproxen Nasal Insulin Nefiracetam Nelonicline Nelotanserin NeoTrofin Neramexane NGX267 NIC5-15 Nicotinamide Nilvadipine Nimodipine NS2330 Octagam®10% ORM-12741 PBT2 PF-05212377 PF-05251749 PF-06648671 PF-06751979 Phenserine Physostigmine Salicylate Pimavanserin Pioglitazone Piromelatine Ponezumab PQ912 Prazosin Prednisone Propentofylline PRX-03140 PRX002 PXT864 Rember TM Repetitive Transcranial Magnetic Stimulation Resveratrol RG3487 RG7129 RG7345 Rilapladib Riluzole Rivastigmine RO 7105705 Rofecoxib Rosiglitazone S 38093 S-Equol S47445 Sabeluzole SAR110894D SAR228810 Saracatinib Sargramostim SB 202026 Semagacestat Sembragiline SGS-742 Simvastatin Solanezumab Souvenaid ST101 Suritozole SUVN-502 SUVN-G3031 T-817MA T3D-959 Tacrine Telmisartan Thalidomide Tideglusib TPI 287 UB 311 Valproate Vanutide cridificar Varenicline Verubecestat Xaliproden XanamemTM Young Plasma Other Go Search By Attributes FDA Status Phase 0 Phase 1 Phase 1/2 Phase 2 Phase 2/3 Phase 3 Phase 4 Approved Inactive Discontinued Not Regulated Target Type alpha-synuclein Amyloid-Related Cholesterol Cholinergic System Inflammation Metals Other Other Neurotransmitters Tau Unknown Therapy Type Dietary Supplement Gene/Stem Cell Immunotherapy (active) Immunotherapy (passive) Other Procedural Intervention Small Molecule Condition Alzheimer's Disease Cerebral Amyloid Angiopathy Frontotemporal Dementia Mild Cognitive Impairment Parkinson's Disease Keyword 0 Therapeutics View Results Reset Search Results Name Synonyms FDA Status Company Target Type Therapy Type Condition Approved For
